Herein we describe the first phosphine-substituted transition metal complexes with terminal coordinated Cp*E ligands (E = Al, Ga; Cp* = pentamethylcyclopentadienyl). The reaction of [(dcpe)Pt(H)(CH 2 t -Bu)] (dcpe = bis(dicyclohexylphosphino)ethane) with Cp*E yields the tetrahedrally coordinated complexes [(dcpe)Pt(AlCp*) 2 ] ( 1 ) and [(dcpe)Pt(GaCp*) 2 ] ( 2 ), respectively. Quantum-chemical DFT calculations on the model complexes [(dhpe)Pt(AlCp) 2 ] ( 1M ) and [(dhpe)Pt(GaCp) 2 ] ( 2M; dhpe = diphosphinoethane) verify rather weak Pt−E bonds for both complexes. A comparison with the complexes [M(ER) 4 ] and [(CO) n M−ER] shows that Cp*E represents a moderate σ-donor/π-acceptor and that the bond strength is strongly influenced by the ancillary ligands at the transition metal center; in particular, (CO) n M fragments give more polar bonds than phosphine-substituted metal centers such as L 2 Pt.
No takes yet. Share an insight, caveat, or question.
Weiss et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: